AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26424587
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg melatonin (in women with sleep disturbances)
Trial: 26424587
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg melatonin (in women with sleep disturbances)
Trial: 24384420
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol sulfate and budesonide administered by inhalation twice a day for 7 days with Heliox
Trial: 18612885
Drug: Cognitive-Behavioral Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Therapy (8 sessions)
Trial: 18612885
Drug: Twelve-step treatment
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Twelve-step treatment (8 sessions)
Trial: 12117401
Drug: Early-phase trials
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early-phase trials for drug/device development
Trial: 10721069
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (epileptics with comparable clinical characteristics and treatment)
Trial: 8628336
Drug: Polyprenoic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyprenoic acid (600 mg daily)
Trial: 21556366
Drug: Epirubicin 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin 90 mg/m²
Trial: 21556366
Drug: Paclitaxel 200
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 200 mg/m²
Trial: 7965263
Drug: Losartan 5
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 5 mg
Trial: 7965263
Drug: Losartan 10
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 10 mg
Trial: 7965263
Drug: Losartan 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 75 mg
Trial: 7815703
Drug: Midazolam 0
RxNorm normalized name: midazolam 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0 mg
Trial: 8694203
Drug: Midazolam 1
RxNorm normalized name: midazolam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 1 mg
Trial: 3758361
Drug: Intra-operative radiotherapy
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-operative radiotherapy (IOR) with doses of 28 to 35 Gy using electron beams
Trial: 27644589
Drug: Ranibizumab plus
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ranibizumab plus prompt laser treatment
Trial: 27644589
Drug: Ranibizumab plus
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ranibizumab plus deferred laser treatment
Trial: 27644589
Drug: Ranibizumab ±
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranibizumab ± laser therapy
Trial: 16723360
Drug: Systemic corticosteroid
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic corticosteroid and/or immunosuppressive treatment
Trial: 15319022
Drug: Olanzapine (1.25-2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (1.25-2.5 mg/day starting dose, titrated to a mean of 14.5 mg/day by trial end)
Trial: 15319022
Drug: Olanzapine (treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (treatment group)
Trial: 11148857
Drug: Tilidine/naloxone solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilidine/naloxone solution (25 mg, 50 mg, 100 mg)
Trial: 11148857
Drug: Tilidine/naloxone solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilidine/naloxone solution (4 x 50 mg tilidine)
Trial: 11148857
Drug: Tilidine/naloxone retard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilidine/naloxone retard tablets (50 mg, 100 mg, 200 mg tilidine/tablet)
Trial: 9489119
Drug: Talc slurry
RxNorm normalized name: Talc
DrugBank: Talc (DB09511)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Talc slurry (5 g in 50 mL saline)
Trial: 9489119
Drug: Bleomycin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bleomycin (1 mg/kg in 50 mL saline)
Trial: 8405501
Drug: Enoxaparin (ENX)
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (ENX) 4200 anti factor Xa IU once daily
Trial: 8405501
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) 7500 IU twice daily
Trial: 3543577
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose heparin-DHE
Trial: 18568185
Drug: Low-dose indapamide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose indapamide (1.5 mg sustained release daily) with added perindopril
Trial: 12435173
Drug: Darbepoetin alfa
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Darbepoetin alfa (Aranesp) at doses < 1.5 microg/kg
Trial: 12435173
Drug: Darbepoetin alfa
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Darbepoetin alfa (Aranesp) at doses 1.5 to 2.25 microg/kg
Trial: 12435173
Drug: Darbepoetin alfa
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Darbepoetin alfa (Aranesp) at doses > 2.25 microg/kg
Trial: 1826911
Drug: Isradipine (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (2.5, 5, 7.5, or 10 mg BID)
Trial: 25808577
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy plus repeated botulinum toxin A (BoNT‐A/OT)
Trial: 22970914
Drug: bFGF treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bFGF treatment (direct application of bFGF drops in the clinic and repeated daily by the patient, n = 53)
Trial: 22970914
Drug: bFGF treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bFGF treatment (n = 53)
Trial: 19176965
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) 3,000 mg daily
Trial: 15560807
Drug: SRP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP and metronidazole (400 mg t.i.d. for 10 days)
Trial: 15560807
Drug: SRP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP and weekly professional supragingival plaque removal for three months (PC)
Trial: 11159875
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg PRU
Trial: 11159875
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg PRU
Trial: 29654645
Drug: Testosterone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (100 mg testosterone enanthate weekly for 7 weeks)
Trial: 26657900
Drug: Split-Dose Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split-Dose Group (SDG) - low-volume 2-L polyethylene glycol (PEG)-ascorbate solution in a 'split-dose' regimen
Trial: 26657900
Drug: Day-Before Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Day-Before Group (DBG) - traditional 'full-dose, day-before' regimen
Trial: 26657900
Drug: Split-Dose Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split-Dose Group (SDG)
Trial: 26021558
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone marrow mononuclear cells within 24 hours (group A, n = 27)
Trial: 26021558
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone marrow mononuclear cells 3 to 7 days after PCI (group B, n = 26)
Trial: 26021558
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 25) - saline infusion performed immediately after emergency PCI
Trial: 26021558
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone marrow mononuclear cells 7 to 30 days after PCI (group C, n = 26)
Trial: 26021558
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone marrow mononuclear cells within 24 hours (group A)
Trial: 26021558
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone marrow mononuclear cells 3 to 7 days after PCI (group B)
Trial: 26021558
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone marrow mononuclear cells 7 to 30 days after PCI (group C)
Trial: 11239222
Drug: Amifostine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amifostine (500 mg single dose)
Trial: 9727725
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E 600 mg per day
Trial: 9727725
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E 1600 mg per day
Trial: 9727725
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (unchanged medication)
Trial: 21750157
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (hGH), 20 μg/kg/day
Trial: 29871262
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy and radiotherapy
Trial: 29871262
Drug: Concurrent radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent radiotherapy and chemotherapy plus adjuvant chemotherapy
Trial: 23256145
Drug: Whole milk
RxNorm normalized name: Calcium fortified whole milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole milk intake (≥237 mL/d or 1 serving/d)
Trial: 8348110
Drug: Nabumetone (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabumetone (1,000 mg once daily)
Trial: 3789368
Drug: Buccal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal morphine 10 mg tablets
Trial: 3789368
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine sulphate 13.5 mg
Trial: 27447721
Drug: Sugar-free beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar-free beverage (250 mL per day) for 18 months
Trial: 24332142
Drug: Full prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full prescription coverage with adherence (proportion of days covered ≥80%) to statin, β-blocker, or angiotensin-converting enzyme inhibitor/angiotensin receptor blocker
Trial: 22418773
Drug: Neratinib 240
RxNorm normalized name: NERATINIB
DrugBank: Neratinib (DB11828)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Neratinib 240 mg once daily (QD)
Trial: 22418773
Drug: Neratinib 120
RxNorm normalized name: NERATINIB
DrugBank: Neratinib (DB11828)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Neratinib 120 mg twice daily (BID)
Trial: 11929644
Drug: 30 microg
RxNorm normalized name: Levonorgestrel 30 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 microg ethinyl estradiol + 2 mg dienogest (30 EE/DNG)
Trial: 11929644
Drug: 20 microg
RxNorm normalized name: Calcifediol 20 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 microg ethinyl estradiol + 2 mg dienogest (20 EE/DNG)
Trial: 11929644
Drug: 10 microg
RxNorm normalized name: Estradiol 10 microgram vaginal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 microg ethinyl estradiol + 2 mg estradiol valerate + 2 mg dienogest (EE/EV/DNG)
Trial: 8588965
Drug: H1 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H1 and H2-receptor-blocking agents in standard dosages preoperatively (Antihistamine group)
Trial: 8588965
Drug: No histamine-receptor-blocking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No histamine-receptor-blocking agents (Control group)
Trial: 28681626
Drug: Fentanyl sublingual
RxNorm normalized name: fentanyl Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl sublingual spray (100, 200, 400, 600, 800 mcg)
Trial: 28681626
Drug: Fentanyl sublingual
RxNorm normalized name: fentanyl Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl sublingual spray (400, 600, 800 mcg)
Trial: 28681626
Drug: Fentanyl sublingual
RxNorm normalized name: fentanyl Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl sublingual spray (600, 800 mcg)
Trial: 23439692
Drug: Weekly reminder
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly reminder calls and homework assignments
Trial: 12775969
Drug: Treprostinil infusion
RxNorm normalized name: Treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Treprostinil infusion
Trial: 16451393
Drug: Subcutaneous desferrioxamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous desferrioxamine (DF)
Trial: 2068599
Drug: ZDV (experimental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZDV (experimental anti-HIV drug)
Trial: 6340975
Drug: 200 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 micrograms salbutamol 4-hourly
Trial: 6340975
Drug: 200 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 micrograms salbutamol 2-hourly
Trial: 20626053
Drug: Control (tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (tape treatment only)
Trial: 12517329
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of low-dose dopamine (3 microg/kg/min)
Trial: 12517329
Drug: Furosemide 5
RxNorm normalized name: furosemide 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 5 mg/hr infusion
Trial: 31796061
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment according to the protocol for tobacco cessation by the Madrid Regional Health Service
Trial: 25092528
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 8) performing exercises in a different order (compound exercises prior to isolation)
Trial: 19220519
Drug: No educational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No educational intervention in Control County (CC)
Trial: 17913754
Drug: 1 MAC
RxNorm normalized name: Macrodantin
DrugBank: Nitrofurantoin (DB00698)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1 MAC sevoflurane administered via the ventilator for 15 min followed by a 15 min washout before CPB
Trial: 17913754
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no sevoflurane administration)
Trial: 18451319
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume of 12 ml/kg
Trial: 11866252
Drug: Standard naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard naltrexone treatment
Trial: 10361962
Drug: Moclobemide 450
RxNorm normalized name: moclobemide
DrugBank: Moclobemide (DB01171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide 450 mg per day
Trial: 10361962
Drug: Clomipramine 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine 150 mg per day
Trial: 1723407
Drug: Current chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current chemotherapy for advanced testicular cancer
Trial: 7258824
Drug: 0.5% FPL‐55712
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% FPL‐55712 (SRS‐A antagonist)
Trial: 7258824
Drug: 1% FPL‐55712
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% FPL‐55712 (SRS‐A antagonist)
Trial: 20522167
Drug: SQ and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ and IV insulin therapy
Trial: 19270234
Drug: Daily hemodialysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily hemodialysis (dHD)
Trial: 17365745
Drug: d,l-fenfluramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d,l-fenfluramine
Trial: 15128636
Drug: Propofol 4
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol 4 to 10 mg x kg(‐1) x hr(‐1) with 60% nitrous oxide in oxygen
Trial: 7872995
Drug: Nebulized salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized salbutamol sulfate (Asmasal) at 0.1 mg/kg
Trial: 7872995
Drug: Nebulized salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized salbutamol sulfate (Asmasal) at 0.2 mg/kg
Trial: 7872995
Drug: Nebulized salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized salbutamol sulfate (Asmasal) at 0.3 mg/kg
Trial: 3243221
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of classroom and home-based curriculum
Trial: 29192349
Drug: Placement of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placement of an antibiotic oral pack on the hard palate for 5 days postoperatively (Group A)
Trial: 29192349
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral pack placed (Group B)
Trial: 22452894
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy plus celecoxib (arm D)
Trial: 22452894
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy alone (control arm A)
Trial: 17609682
Drug: Dose adjustment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose adjustment
Trial: 15806597
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of EX/RP and CMI (EX/RP+CMI)
Trial: 7879933
Drug: Atracurium (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium (0.5 mg.kg-1)
Trial: 7879933
Drug: Vecuronium (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (0.1 mg.kg-1)
Trial: 2196355
Drug: Dexamethasone, 2
RxNorm normalized name: Dexamethasone, 2 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone, 2 mg/kg/day by intravenous injection during the first 7 days of life (group A1)
Trial: 2196355
Drug: 10% dextrose
RxNorm normalized name: Aminosyn II 4.25% in 10% Dextrose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% dextrose solution placebo (group A2)
Trial: 30659815
Drug: Short-term ontopsychological
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term ontopsychological psychotherapy plus routine medical therapy
Trial: 30659815
Drug: Routine medical
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine medical therapy only
Trial: 20147571
Drug: MRK-409 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRK-409 at a dose of 2 mg
Trial: 20147571
Drug: MRK-409 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRK-409 at a dose of 1 mg
Trial: 19672771
Drug: CDA 0.14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDA 0.14 mg/kg/day for 5 days (Arm A)
Trial: 19672771
Drug: CDA 0.14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDA 0.14 mg/kg/day once weekly for 5 weeks (Arm B)
Trial: 15100717
Drug: 3.5 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 g/day fish oil (1.5 g/day n-3 fatty acids)
Trial: 11167438
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg at induction and ondansetron 0.13 mg with each 1-mg bolus dose of morphine